BRAF mutations are found in 1.5 ~ 8% of NSCLC cases, with a balanced repartition between V600 and non-V600 mutation types, and BRAF V600E mutations seem to be more frequent in female and never-smoker patients [303–305]. This evidence concerns the gene BRAF and non-small cell lung carcinoma.